Lipids and Steroids in Cardiovascular Disease - Leptin Improves Cardiac Structure and Function in Patients With Generalized Lipodystrophy
Rebecca J Brown, MD
National Institutes of Health, MD, United States
Presentations in This Video
Lipids and Steroids in Cardiovascular Disease - Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
Konstantinos Stefanakis, MD Student
Beth Israel Deaconess Medical Center, Harvard Medical School; Boston VA Healthcare System, Greece
Lipids and Steroids in Cardiovascular Disease - The Impact of ACTH on Peripheral Steroids Differs between Unilateral and Bilateral Primary Aldosteronism
Yuta Tezuka, MD, PhD
UNIVERSITY OF MICHIGAN, MI, United States
Lipids and Steroids in Cardiovascular Disease - Chair
Jeremy W Tomlinson, BA,BM,BCH,MRCP,MD
University of Oxford, United Kingdom
Lipids and Steroids in Cardiovascular Disease - Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
Emilie Gobeil, BSc
Laval University, QC, Canada